Skip to main content
Shenzhen Salubris Pharmaceuticals Co., Ltd. logo

Shenzhen Salubris Pharmaceuticals Co., Ltd. — Investor Relations & Filings

Ticker · 002294 ISIN · CNE100000FW8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,658 across all filing types
Latest filing 2017-03-20 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002294

About Shenzhen Salubris Pharmaceuticals Co., Ltd.

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co., Ltd. is a research-driven enterprise focused on the development, manufacturing, and commercialization of innovative drugs and medical devices. The company specializes in therapeutic areas including cardiovascular diseases, chronic kidney disease, and metabolic disorders. Its product portfolio features proprietary treatments such as Allisartan Isoproxil for hypertension and Clopidogrel Bisulfate for anti-platelet therapy. Salubris maintains an integrated value chain encompassing research and development, active pharmaceutical ingredient production, and finished dosage manufacturing. The firm emphasizes innovation through its dedicated R&D centers and strategic focus on biologics and small molecule drugs, aiming to provide comprehensive clinical solutions for chronic conditions.

Recent filings

Filing Released Lang Actions
2016年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2016 年年度报告全文" which translates to "2016 Annual Report Full Text" for Shenzhen Salubris Pharmaceuticals Co., Ltd. It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, and auditor information. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. It includes comprehensive financial figures, business analysis, and corporate governance information, consistent with an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2016
2017-03-20 Chinese
第四届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shenzhen Salubris Pharmaceuticals Co., Ltd. It includes decisions on electing the chairman of the Supervisory Board, approval of the 2016 Supervisory Board work report, approval of the 2016 annual report and its summary, approval of the 2016 profit distribution plan, internal control self-evaluation report, and proposals to increase business scope and amend the company charter. The document states that these reports and proposals will be submitted to the 2016 annual shareholders meeting for approval. The document itself is a meeting resolution announcement and does not contain the full annual report or detailed financial statements but references where these can be found. The document length is 3354 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and related corporate governance matters, not the full annual report or other detailed filings.
2017-03-20 Chinese
关于参与设立股权投资基金的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Xinlitai Pharmaceutical Co., Ltd. regarding the progress of its participation in establishing an equity investment fund. It includes details about the fund's registration, legal compliance, and investment focus. The document is relatively short (1470 characters) and serves as a progress update or announcement rather than a detailed financial report or regulatory filing. It does not contain financial statements, audit information, or management discussion. It is not a report publication announcement since it does not mention the release or availability of a report. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing activities and investment fund participation.
2017-03-14 Chinese
关于选举职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor (监事) following a resignation. It includes details about the election process, the new appointee's qualifications, and compliance with relevant laws and regulations. There are no financial statements, earnings data, or detailed management discussion. The document is a formal announcement about a change in the supervisory board, which falls under Board/Management Information (MANG). The document length is short and it is not a report or a presentation but an official announcement of a board-related change.
2017-03-03 Chinese
关于职工代表监事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company's employee representative supervisor and the subsequent impact on the supervisory board's composition. It includes details about the resignation, legal compliance, and plans to fill the vacancy. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content is about management/board changes specifically related to supervisory board members. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on personnel changes, confirming this classification.
2017-02-14 Chinese
2016年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2016 年度业绩快报" which translates to "2016 Annual Performance Express Report" or "Annual Earnings Quick Report." It contains preliminary financial data for the full year 2016, including revenue, profit, net profit attributable to shareholders, earnings per share, and return on equity. The data is described as preliminary and unaudited by an accounting firm, with a disclaimer about possible differences from the final annual report. The document also includes explanations of business performance and financial condition, and references internal audit reports and signed financial statements. The length is about 1600 characters, which is short but contains substantive financial data and analysis for the full fiscal year. This matches the characteristics of an Earnings Release (ER) rather than a full Annual Report (10-K) or Interim Report (IR). It is not a report publication announcement since it contains actual financial data, not just a notice. Therefore, the best classification is Earnings Release (ER). FY 2016
2017-01-23 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.